156 related articles for article (PubMed ID: 15084005)
1. Medical treatment of hyperadrenocorticism in the dog.
Braddock JA
Aust Vet J; 2003; 81(1-2):31-3. PubMed ID: 15084005
[No Abstract] [Full Text] [Related]
2. Hyperadrenocorticism: treating dogs.
Brown CG; Graves TK
Compend Contin Educ Vet; 2007 Mar; 29(3):132-4, 136, 138 passim; quiz 144-5. PubMed ID: 17726933
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of pituitary-dependent hyperadrenocorticism in dogs.
Peterson ME; Kintzer PP
Semin Vet Med Surg Small Anim; 1994 Aug; 9(3):127-31. PubMed ID: 7938931
[No Abstract] [Full Text] [Related]
4. Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane.
Reine NJ
Clin Tech Small Anim Pract; 2007 Feb; 22(1):18-25. PubMed ID: 17542193
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the survival times of dogs treated with mitotane or trilostane for pituitary-dependent hyperadrenocorticism.
Barker EN; Campbell S; Tebb AJ; Neiger R; Herrtage ME; Reid SW; Ramsey IK
J Vet Intern Med; 2005; 19(6):810-5. PubMed ID: 16355673
[TBL] [Abstract][Full Text] [Related]
6. [Cushing's syndrome. Medical treatment of adrenal hypercorticism].
Bricaire H; Luton JP
Horm Res; 1980; 13(4-5):317-24. PubMed ID: 7274999
[No Abstract] [Full Text] [Related]
7. Old or new? A comparison of mitotane and trilostane for the management of hyperadrenocorticism.
Griffies JD
Compend Contin Educ Vet; 2013 May; 35(5):E3. PubMed ID: 23677783
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Cushing's disease in children.
Bergstrand CG; Nilsson KO
Acta Paediatr Scand; 1982 Jan; 71(1):1-6. PubMed ID: 6291313
[No Abstract] [Full Text] [Related]
9. Comparison of non-selective adrenocorticolysis with mitotane or trilostane for the treatment of dogs with pituitary-dependent hyperadrenocorticism.
Clemente M; De Andrés PJ; Arenas C; Melián C; Morales M; Pérez-Alenza MD
Vet Rec; 2007 Dec; 161(24):805-9. PubMed ID: 18083978
[TBL] [Abstract][Full Text] [Related]
10. Problems associated with medical therapy of canine hyperadrenocorticism.
Nichols R
Probl Vet Med; 1990 Dec; 2(4):551-6. PubMed ID: 2134073
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of occult hyperadrenocorticism with mitotane but not trilostane in a dog.
Park SM; Kim KB; Song WJ; Youn HY
Vet Med Sci; 2021 Jul; 7(4):1150-1153. PubMed ID: 33755348
[TBL] [Abstract][Full Text] [Related]
12. A comparison of factors that influence survival in dogs with adrenal-dependent hyperadrenocorticism treated with mitotane or trilostane.
Helm JR; McLauchlan G; Boden LA; Frowde PE; Collings AJ; Tebb AJ; Elwood CM; Herrtage ME; Parkin TD; Ramsey IK
J Vet Intern Med; 2011; 25(2):251-60. PubMed ID: 21352377
[TBL] [Abstract][Full Text] [Related]
13. Adrenocorticotropic hormone levels in dogs with pituitary-dependent hyperadrenocorticism following trilostane therapy.
Witt AL; Neiger R
Vet Rec; 2004 Mar; 154(13):399-400. PubMed ID: 15083974
[No Abstract] [Full Text] [Related]
14. Long-term survival of dogs with adrenal-dependent hyperadrenocorticism: a comparison between mitotane and twice daily trilostane treatment.
Arenas C; Melián C; Pérez-Alenza MD
J Vet Intern Med; 2014; 28(2):473-80. PubMed ID: 24495125
[TBL] [Abstract][Full Text] [Related]
15. The medical treatment of Cushing's syndrome.
Miller JW; Crapo L
Endocr Rev; 1993 Aug; 14(4):443-58. PubMed ID: 7693447
[No Abstract] [Full Text] [Related]
16. Medical treatment of pituitary-dependent hyperadrenocorticism in dogs: should L-deprenyl (Anipryl) ever be used?
Peterson ME
J Vet Intern Med; 1999; 13(4):289-90. PubMed ID: 10449217
[No Abstract] [Full Text] [Related]
17. Use of aminoglutethimide in the treatment of pituitary-dependent hyperadrenocorticism in the dog.
Pérez AM; Guerrero B; Melián C; Ynaraja E; Peña L
J Small Anim Pract; 2002 Mar; 43(3):104-8. PubMed ID: 11924551
[TBL] [Abstract][Full Text] [Related]
18. Hair chewing associated with suspected hyperadrenocorticism in a dog.
Chastain CB
J Am Vet Med Assoc; 1978 Mar; 172(5):573-4. PubMed ID: 632195
[TBL] [Abstract][Full Text] [Related]
19. Comments on use of mitotane.
Watson AD
J Am Vet Med Assoc; 1995 Jan; 206(1):25. PubMed ID: 7744655
[No Abstract] [Full Text] [Related]
20. Long-term outcome of myotonia associated with hyperadrenocorticism in 2 dogs.
Nagata N; Yuki M
Can Vet J; 2015 Sep; 56(9):931-3. PubMed ID: 26347041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
